Literature DB >> 28508989

Evaluation of inner retinal layers with optic coherence tomography in vigabatrin-exposed patients.

Betül Tuğcu1, Mesrure Köseoğlu Bitnel2, Fatma Selin Kaya3, Betül Tekin Güveli4, Dilek Ataklı2.   

Abstract

In order to reveal the underlying retinal pathology leading to dysfunction in vigabatrin-exposed patients, we aimed to evaluate the inner retinal layers encompassing ganglion cell complex (GCC) layer and inner plexiform layer with new generation optic coherence tomography (OCT). Fourteen patients with epilepsy and exposure to vigabatrin and 12 clinically normal individuals, constituting the control group, were included. Retinal images were obtained using spectral-domain OCT (Optovue RTVue Fourier domain). Nasal and superior quadrants of retinal nerve fiber layer (RNFL) were found to be significantly lower in the patient group compared to the controls (p < 0.01). No significant difference was shown in the thickness of GCC layer (p > 0.05). Foveal thickness was significantly higher in the patient group (p: 0.006), but no significant difference was found in perifoveal and parafoveal regions between groups (p > 0.05). The thickness of RNFL was found to be lower in vigabatrin-exposed patients without any reduction in GCC layer in the macular region. However, foveal thickness was found to be significantly higher compared to perifoveal and parafoveal macular regions in vigabatrin-exposed patients. In conclusion, OCT revealed reduced thickness of RNFL without any reduction in ganglion cell layer in our study. The objective quantitative assessment of OCT is a practical noninvasive method and it can have role in future monitoring of these patients.

Entities:  

Keywords:  Anticonvulsants; Epilepsy; Optic coherence tomography; Retina; Vigabatrin

Mesh:

Substances:

Year:  2017        PMID: 28508989     DOI: 10.1007/s10072-017-2971-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  21 in total

1.  Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss--could scanning laser polarimetry aid diagnosis?

Authors:  J M Durnian; L G Clearkin
Journal:  Eye (Lond)       Date:  2007-03-30       Impact factor: 3.775

2.  The ocular side effects of vigabatrin (Sabril): information and guidance for screening.

Authors:  M J Hawker; N J Astbury
Journal:  Eye (Lond)       Date:  2008-05-23       Impact factor: 3.775

3.  Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.

Authors:  E A Wilson; M J Brodie
Journal:  BMJ       Date:  1997-06-07

4.  Severe persistent visual field constriction associated with vigabatrin.

Authors:  T Eke; J F Talbot; M C Lawden
Journal:  BMJ       Date:  1997-01-18

5.  Electrophysiological Evidences of Visual Field Alterations in Children Exposed to Vigabatrin Early in Life.

Authors:  Noémie Hébert-Lalonde; Lionel Carmant; Philippe Major; Marie-Sylvie Roy; Maryse Lassonde; Dave Saint-Amour
Journal:  Pediatr Neurol       Date:  2016-03-17       Impact factor: 3.372

6.  Vigabatrin effect on inner retinal function.

Authors:  S G Coupland; D H Zackon; B C Leonard; T M Ross
Journal:  Ophthalmology       Date:  2001-08       Impact factor: 12.079

7.  Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.

Authors:  John M Wild; Catherine R Robson; Adrian L Jones; Ian A Cunliffe; Philip E M Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

8.  Dissecting the phenotype in genome-wide association studies of psychiatric illness.

Authors:  Nick Craddock; Kenneth Kendler; Michael Neale; John Nurnberger; Shaun Purcell; Marcella Rietschel; Roy Perlis; Susan L Santangelo; Thomas G Schulze; Thomas Schulze; Jordan W Smoller; Anita Thapar
Journal:  Br J Psychiatry       Date:  2009-08       Impact factor: 9.319

9.  Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity.

Authors:  Charlotte Lawthom; Philip E M Smith; John M Wild
Journal:  Ophthalmology       Date:  2009-01-24       Impact factor: 12.079

10.  Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness.

Authors:  G Vizzeri; R N Weinreb; A O Gonzalez-Garcia; C Bowd; F A Medeiros; P A Sample; L M Zangwill
Journal:  Br J Ophthalmol       Date:  2009-03-19       Impact factor: 4.638

View more
  3 in total

1.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

2.  Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues.

Authors:  Dana C Walters; Erland Arning; Teodoro Bottiglieri; Erwin E W Jansen; Gajja S Salomons; Madalyn N Brown; Michelle A Schmidt; Garrett R Ainslie; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Neurochem Int       Date:  2019-02-26       Impact factor: 3.921

3.  Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.

Authors:  Dana C Walters; Erwin E W Jansen; Garrett R Ainslie; Gajja S Salomons; Madalyn N Brown; Michelle A Schmidt; Jean-Baptiste Roullet; K M Gibson
Journal:  Pharmacol Res Perspect       Date:  2019-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.